<DOC>
	<DOCNO>NCT00005875</DOCNO>
	<brief_summary>RATIONALE : Drugs use chemotherapy use different way stop tumor cell divide stop grow die . PURPOSE : Phase II trial study effectiveness nitrocamptothecin treat patient metastatic melanoma .</brief_summary>
	<brief_title>Nitrocamptothecin Treating Patients With Metastatic Melanoma</brief_title>
	<detailed_description>OBJECTIVES : I. Assess efficacy toxicity nitrocamptothecin patient metastatic melanoma . OUTLINE : Patients stratify accord disease ( choroidal v nonchoroidal ) . Patients receive oral nitrocamptothecin daily day 1-5 . Treatment continue weekly least 8 week ( 2 course ) absence disease progression unacceptable toxicity . PROJECTED ACCRUAL : A total 28-74 patient ( 14-37 per stratum ) accrue study .</detailed_description>
	<mesh_term>Melanoma</mesh_term>
	<mesh_term>Rubitecan</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Histologically cytologically confirm metastatic melanoma Choroidal ( prior chemotherapy require ) OR Nonchoroidal No 3 chemotherapy regimen Bidimensionally measurable disease No symptomatic uncontrolled CNS involvement include extensive brain metastasis , spinal cord compression , meningeal carcinomatosis Not eligible treatment protocol high priority PATIENT CHARACTERISTICS : Age : Over 16 Performance status : Zubrod 02 Life expectancy : Greater 8 week Hematopoietic : Absolute neutrophil count least 1,000/mm3 Platelet count least 100,000/mm3 Hepatic : Bilirubin great 1.5 time upper limit normal ( ULN ) Transaminase great 3 time ULN Renal : Creatinine great 2.0 mg/dL Other : Not pregnant nursing Negative pregnancy test Fertile patient must use effective contraception 1 year study No serious concurrent illness PRIOR CONCURRENT THERAPY : Biologic therapy : Not specify Chemotherapy : See Disease Characteristics At least 3 week since prior chemotherapy recover Endocrine therapy : Not specify Radiotherapy : At least 3 week since prior radiotherapy recover Surgery : Not specify</criteria>
	<gender>All</gender>
	<minimum_age>16 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2001</verification_date>
	<keyword>stage IV melanoma</keyword>
	<keyword>recurrent melanoma</keyword>
</DOC>